However, RAS-transformed cells lead to activation of downstream signalling driven by EGFR, a cell surface receptor highly involved in chordomas, mimicking upstream receptor tyrosine kinase (RTK) activation (Burger et al., 2014). The gene discussed is EGFR; the disease is chordoma.